eaonc.bsky.social
Biomarker-driven medical research involving adults who have or are at risk of developing cancer
👤 Joined on 26 November 2024
Followers
Following
Total Posts
@eaonc.bsky.socialCan patients with high anatomic risk but low genomic risk for early-stage ER+/HER2- #breastcancer do similarly well without #chemotherapy? A new @eaonc.bsky.social #trial aims to evaluate the benefits for this subgroup.
Show PostThank you for sharing our powerful five-minute video @eaonc.bsky.social! I really helps frame clinical trials from the participant's point of view.
Show PostClinical trials help advance cancer research and care—but they depend on people willing to participate. Our new film shares one participant’s story and the vital role volunteers play in improving cancer treatment. You can view the five-minute #RewritingCancer film here: https://bit.ly/Alliance-Video
Show Post"Cancer statistics, 2026: Charting a course for a national cancer research agenda," commentary by Dr. Primo Lara, Jr, & @drdawnhershman.bsky.social publ w the annual portrait of U.S. #cancer stats in CA: A Cancer Journal for Clinicians, just out! #NCTN #NCORP @eaonc.bsky.social @nrgonc.bsky.social
Show PostECOG-ACRIN, Caris present breast cancer recurrence and risk stratification AI tools (@eaonc.bsky.social) https://cancerletter.com/clinical-roundup/20251212_6a/
Show Post